Literature DB >> 18417271

Ethically acceptable prioritisation of childless couples and treatment rationing: "accountability for reasonableness".

Håkan Lindström1, Susanne Waldau.   

Abstract

OBJECTIVE: With in vitro fertilisation serving as a specific case, an intervention was aimed at investigating the potential for applying prioritisation theories and methods in a real-life situation to form an evidence-based proposal that met the standards of the "Accountability for Reasonableness" Model. In turn, this case would serve as a basis for public decision on rationalisation, prioritisation and rationing, whereby given resources are allocated with respect to the ethical template of the Swedish Parliament's decision on priorities in health care. STUDY
DESIGN: Management representatives of the overall county council as well as the gynaecologic-obstetric department levels, infertility treatment professionals and a patients' organisation representative worked together to create guidelines building on the ethical principles of human dignity, needs/solidarity and cost-effectiveness, on evidence of treatment effect, epidemiology and economic resources availability. Also quality improvement techniques were used.
RESULTS: Due to new guidelines for priority setting, it is expected that more childless couples in the studied health care region will get publicly financed IVF treatment. IVF treatment outcome is expected to be more cost-effective in terms of pregnancies for a given amount of resources. A balance between needs - as defined by the guidelines' criteria - and resources is expected and thus waiting lists are expected to vanish. The patients' organisations representative accepted the guidelines. They were also accepted by all obstetric clinics and formally agreed upon by the political boards of all county councils in the region.
CONCLUSION: Use of a deliberative decisions model, structured quality improvement methodology and an accepted model for prioritisation helped create a system for legitimate prioritisation of couples and rationing of treatment regarding a group of patients where differentiation has been considered difficult.

Entities:  

Mesh:

Year:  2008        PMID: 18417271     DOI: 10.1016/j.ejogrb.2008.02.018

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  Should there be a female age limit on public funding for assisted reproductive technology?

Authors:  Drew Carter; Amber M Watt; Annette Braunack-Mayer; Adam G Elshaug; John R Moss; Janet E Hiller
Journal:  J Bioeth Inq       Date:  2013-01-04       Impact factor: 1.352

2.  Male fertility and reduction in semen parameters: a single tertiary-care center experience.

Authors:  D Milardi; G Grande; D Sacchini; A L Astorri; G Pompa; A Giampietro; L De Marinis; A Pontecorvi; A G Spagnolo; R Marana
Journal:  Int J Endocrinol       Date:  2012-01-26       Impact factor: 3.257

Review 3.  Sustainability in health care by allocating resources effectively (SHARE) 4: exploring opportunities and methods for consumer engagement in resource allocation in a local healthcare setting.

Authors:  Claire Harris; Henry Ko; Cara Waller; Pamela Sloss; Pamela Williams
Journal:  BMC Health Serv Res       Date:  2017-05-05       Impact factor: 2.655

4.  Priority setting in health care: a complementary approach.

Authors:  Rui Nunes; Guilhermina Rego
Journal:  Health Care Anal       Date:  2014-09

5.  Sustainability in Health care by Allocating Resources Effectively (SHARE) 9: conceptualising disinvestment in the local healthcare setting.

Authors:  Claire Harris; Sally Green; Wayne Ramsey; Kelly Allen; Richard King
Journal:  BMC Health Serv Res       Date:  2017-09-08       Impact factor: 2.655

6.  Sustainability in Health care by Allocating Resources Effectively (SHARE) 10: operationalising disinvestment in a conceptual framework for resource allocation.

Authors:  Claire Harris; Sally Green; Adam G Elshaug
Journal:  BMC Health Serv Res       Date:  2017-09-08       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.